Pharmaceuticals Antibiotics Market Forecast to 2028...

Antibiotics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Drug Class (Sulfonamides, Aminoglycosides, Carbapenem, Macrolides, Fluoroquinolones, Penicillin, Cephalosporin, Others); Action Mechanism (Mycolic Acid Inhibitors, RNA Synthesis Inhibitors, DNA Synthesis Inhibitors, Protein Synthesis Inhibitors, Cell Wall Synthesis Inhibitors), and Geography

Publication Month: Apr 2021 | Report Code: TIPRE00003406 | No. of Pages: 161 | Category: Pharmaceuticals | Status: Published

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

The antibiotics market was valued at US$ 44,111.31 million in 2020 and is projected to reach US$ 59,253.24 million in 2028; it is expected to grow at a CAGR of 4.0% during 2021–2028.

Antibiotics are powerful medicines that are used to fight against bacterial infections and diseases. These are specifically used to treat infections caused by bacteria such as, Staph., Strep., or E. coli. Antibiotics either kill the bacteria (bactericidal) or restrict it from reproducing and growing (bacteriostatic). The antibiotics market do not work against any viral infection. Some of the common infections treated with antibiotics are, conjunctivitis, skin or soft tissue infection, upper respiratory tract infection, bronchitis, streptococcal pharyngitis (strep throat), and among others.

Lucrative Regional Antibiotics Markets

Lucrative Regional Antibiotics Markets

Get more information on this report :


Market Insights

Increasing Development of Generic Drugs

A generic medicine is a copy of a branded drug that is no longer under patent. Generic versions are introduced in the market with an aim to offer cost-efficient drugs and increase the reach of these drugs to people belonging to different economic classes. Generic versions are popular due to their availability and affordability. For instance, according to a study published on the NCBI in 2018, the average brand name prescription price was almost 4-times the average generic price. Additionally, the companies are also focusing on the development of generic versions with an aim to offer antibiotics at minimal costs. For instance, in June 2018, Lupin launched generic Tobramycin inhalation solution in the US market. Further, encouragement from government authorities is also projected to drive the production of generic antibiotics, which would eventually drive the growth of the antibiotics market during the forecast period. For instance, in February 2019, the US Food and Drug Administration (US FDA) announced approval for commercialization of generic medicines manufactured by Indian drug companies in the US.

Test Type Insights

Based on drug class, the antibiotics market is segmented into sulfonamides, aminoglycosides, carbapenem, macrolides, fluoroquinolones, penicillin, cephalosporin, and others. The cephalosporin segment held the largest share of the market in 2020; whereas the fluoroquinolones segment is anticipated to register the highest CAGR in the market during the forecast period.

Global Antibiotics Market, by Product Type – 2020 & 2028

Global Antibiotics Market, by Product Type – 2020 & 2028

Get more information on this report :


Action-Mechanism Insights

Based on action mechanism, the antibiotics market has been segmented into mycolic acid inhibitors, RNA synthesis inhibitors, DNA synthesis inhibitors, protein synthesis inhibitors, and cell wall synthesis inhibitors. The cell wall synthesis inhibitors segment held the largest share of the market in 2020, whereas the DNA synthesis inhibitors segment is estimated to register the highest CAGR in the market during the forecast period.

Strategic Insights

Product launches and approval strategies are commonly adopted by companies to expand their footprint and product portfolio worldwide and meet the growing demand.

The market players operating in the antibiotics market adopt the strategy of expansion to enlarge customer base across the world, which also permits the players to maintain their brand name globally. For instance, in July 2019, the company such as Pfizer has launched an international research consortium to discover and develop new TB antibiotics in collaboration with eight biotechnology partners and European academic.

Global Antibiotics Market – By Drug Class

  • Cephalosporin
  • Penicillin
  • Fluoroquinolones
  • Macrolides
  • Carbapenem
  • Aminoglycosides
  • Sulfonamides
  • Others

Global Antibiotics Market – By Action Mechanism

  • Cell Wall Synthesis Inhibitors
  • Protein Synthesis Inhibitors
  • DNA Synthesis Inhibitors
  • RNA Synthesis Inhibitors
  • Mycolic Acid Inhibitors
  • Others

Global Antibiotics  – By Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • UK
    • Spain
    • Rest of Europe
  • Asia Pacific (APAC)
    • China
    • India
    • South Korea
    • Japan
    • Australia
    • Rest of Asia Pacific
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of Middle East and Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Company Profiles

  • Pfizer, Inc
  • Johnson & Johnson Services, Inc. (Janssen Pharmaceuticals),
  • Abbott,
  •  GlaxoSmithKline Plc,
  • Sanofi,
  •  Novartis AG,
  •  Bayer AG,
  • Bristol Myers Squibb Company,
  • Eli Lilly and Company,
  • Astellas Pharma

 

1.            Introduction

1.1       Scope of the Study

1.2       The Insight Partners Research Report Guidance

1.3       Market Segmentation

1.3.1        Global Antibiotics Market – By Drug Class

1.3.2        Global Antibiotics Market – By Action Mechanism

1.3.3        Global Antibiotics Market – By Geography

2.            Antibiotics Market – Key Takeaways

3.            Research Methodology

3.1       Coverage

3.2       Secondary Research

3.3       Primary Research

4.            Global Antibiotics Market – Market Landscape

4.1       Pest Analysis

4.1.1        North America– PEST Analysis

4.1.2        Europe– PEST Analysis

4.1.3        Asia Pacific

4.1.4        Middle East & Africa

4.1.5        South & Central America

5.            Antibiotics Market – Key Market Dynamics

5.1       Market Drivers

5.1.1        Rising Prevalence of Bacterial Infections

5.1.2        Increasing Development of Generic Drugs

5.2       Market Restraints

5.2.1        Tedious and Expensive Process of Antibiotic Development

5.3       Market Opportunities

5.3.1        Growing Investments to Combat Antimicrobial Resistance

5.4       Future Trends

5.4.1        Incorporation of Novel Computing Technologies for Antibiotics Discovery

5.5       Impact analysis

6.            Antibiotics Market – Global Analysis

6.1       Global Antibiotics Market Revenue Forecast And Analysis

6.2       Global Antibiotics Market, By Geography - Forecast And Analysis

6.3       Market Positioning of Key Players

7.            Antibiotics Market Analysis – By Drug Class

7.1       Overview

7.2       Antibiotics Market Revenue Share, by Drug Class (2020 and 2028)

7.3       Sulfonamides

7.3.1        Overview

7.3.2        Sulfonamides: Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

7.4       Aminoglycosides

7.4.1        Overview

7.4.2        Aminoglycosides: Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

7.5       Carbapenem

7.5.1        Overview

7.5.2        Carbapenem: Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

7.6       Macrolides

7.6.1        Overview

7.6.2        Macrolides: Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

7.7       Fluoroquinolones

7.7.1        Overview

7.7.2        Fluoroquinolones: Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

7.8       Penicillin

7.8.1        Overview

7.8.2        Penicillin: Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

7.9       Cephalosporin

7.9.1        Overview

7.9.2        Cephalosporin: Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

7.10    Others

7.10.1     Overview

7.10.2     Others: Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

8.            Antibiotics Market – By Action Mechanism

8.1       Overview

8.2       Antibiotics Market, by Action Mechanism, 2020 and 2028 (%)

8.3       Mycolic Acid Inhibitors

8.3.1        Overview

8.3.2        Mycolic Acid Inhibitors: Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

8.4       RNA Synthesis Inhibitors

8.4.1        Overview

8.4.2        RNA Synthesis Inhibitors: Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

8.5       DNA Synthesis Inhibitors

8.5.1        Overview

8.5.2        DNA Synthesis Inhibitors: Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

8.6       Protein Synthesis Inhibitors

8.6.1        Overview

8.6.2        Protein Synthesis Inhibitors: Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

8.7       Cell Wall Synthesis Inhibitors

8.7.1        Overview

8.7.2        Cell Wall Synthesis Inhibitors: Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

8.8       Others

8.8.1        Overview

8.8.2        Others: Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

9.            Antibiotics Market – Geographic Analysis

9.1       North America: Antibiotics Market

9.1.1        Overview

9.1.2        North America: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)

9.1.3        North America: Antibiotics Market, by Drug Class, 2019–2028 (USD Million)

9.1.4        North America: Antibiotics Market, by Action Mechanism, 2019–2028 (USD Million)

9.1.5        North America: Antibiotics Market, by Country, 2020 & 2028 (%)

9.1.6        US: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)

9.1.6.1      US: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)

9.1.6.2      US: Antibiotics Market, by Drug Class, 2019–2028 (USD Million)

9.1.6.3      US: Antibiotics Market, by Action Mechanism, 2019–2028 (USD Million)

9.1.7        Canada: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)

9.1.7.1      Canada: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)

9.1.7.2      Canada: Antibiotics Market, by Drug Class, 2019–2028 (USD Million)

9.1.7.3      Canada: Antibiotics Market, by Action Mechanism, 2019–2028 (USD Million)

9.1.8        Mexico: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)

9.1.8.1      Mexico: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)

9.1.8.2      Mexico: Antibiotics Market, by Drug Class, 2019–2028 (USD Million)

9.1.8.3      Mexico: Antibiotics Market, by Action Mechanism, 2019–2028 (USD Million)

9.2       Europe: Antibiotics Market

9.2.1        Overview

9.2.2        Europe: Antibiotics Market - Revenue and Forecast to 2028 (USD Million)

9.2.3        Europe: Antibiotics Market, by Drug Class, 2019–2028 (USD Million)

9.2.4        Europe: Antibiotics Market, by Action Mechanism, 2019–2028 (USD Million)

9.2.5        Europe: Antibiotics Market, by Country, 2020 & 2028 (%)

9.2.6        Germany: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)

9.2.6.1      Germany: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)

9.2.6.2      Germany: Antibiotics Market, by Drug Class, 2019–2028 (USD Million)

9.2.6.3      Germany: Antibiotics Market, by Action Mechanism, 2019–2028 (USD Million)

9.2.7        UK: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)

9.2.7.1      UK: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)

9.2.7.2      UK: Antibiotics Market, by Drug Class, 2019–2028 (USD Million)

9.2.7.3      UK: Antibiotics Market, by Action Mechanism, 2019–2028 (USD Million)

9.2.8        France: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)

9.2.8.1      France: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)

9.2.8.2      France: Antibiotics Market, by Drug Class, 2019–2028 (USD Million)

9.2.8.3      France: Antibiotics Market, by Action Mechanism, 2019–2028 (USD Million)

9.2.9        Spain: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)

9.2.9.1      Spain: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)

9.2.9.2      Spain: Antibiotics Market, by Drug Class, 2019–2028 (USD Million)

9.2.9.3      Spain: Antibiotics Market, by Action Mechanism, 2019–2028 (USD Million)

9.2.10     Italy: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)

9.2.10.1   Italy: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)

9.2.10.2   Italy: Antibiotics Market, by Drug Class, 2019–2028 (USD Million)

9.2.10.3   Italy: Antibiotics Market, by Action Mechanism, 2019–2028 (USD Million)

9.3       Asia Pacific: Antibiotics Market

9.3.1        Overview

9.3.2        Asia Pacific: Antibiotics Market - Revenue and Forecast to 2028 (USD Million)

9.3.3        Asia Pacific: Antibiotics Market, by Drug Class, 2019–2028 (USD Million)

9.3.4        Asia Pacific: Antibiotics Market, by Action Mechanism, 2019–2028 (USD Million)

9.3.5        Asia Pacific: Antibiotics Market, by Country, 2020 & 2028 (%)

9.3.6        China: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)

9.3.6.1      China: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)

9.3.6.2      China: Antibiotics Market, by Drug Class, 2019–2028 (USD Million)

9.3.6.3      China: Antibiotics Market, by Action Mechanism, 2019–2028 (USD Million)

9.3.7        Japan: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)

9.3.7.1      Japan: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)

9.3.7.2      Japan: Antibiotics Market, by Drug Class, 2019–2028 (USD Million)

9.3.7.3      Japan: Antibiotics Market, by Action Mechanism, 2019–2028 (USD Million)

9.3.8        India: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)

9.3.8.1      India: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)

9.3.8.2      India: Antibiotics Market, by Drug Class, 2019–2028 (USD Million)

9.3.8.3      India: Antibiotics Market, by Action Mechanism, 2019–2028 (USD Million)

9.3.9        South Korea: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)

9.3.9.1      South Korea: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)

9.3.9.2      South Korea: Antibiotics Market, by Drug Class, 2019–2028 (USD Million)

9.3.9.3      South Korea: Antibiotics Market, by Action Mechanism, 2019–2028 (USD Million)

9.3.10     Australia: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)

9.3.10.1   Australia: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)

9.3.10.2   Australia: Antibiotics Market, by Drug Class, 2019–2028 (USD Million)

9.3.10.3   Australia: Antibiotics Market, by Action Mechanism, 2019–2028 (USD Million)

9.4       Middle East & Africa: Antibiotics Market

9.4.1        Overview

9.4.2        Middle East & Africa: Antibiotics Market - Revenue and Forecast to 2028 (USD Million)

9.4.3        Middle East & Africa: Antibiotics Market, by Drug Class, 2019–2028 (USD Million)

9.4.4        Middle East & Africa: Antibiotics Market, by Action Mechanism, 2019–2028 (USD Million)

9.4.5        Middle East & Africa: Antibiotics Market Share by Country – 2019 & 2027, (%)

9.4.6        Saudi Arabia: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)

9.4.6.1      Saudi Arabia: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)

9.4.6.2      Saudi Arabia: Antibiotics Market, by Drug Class, 2019–2028 (USD Million)

9.4.6.3      Saudi Arabia: Antibiotics Market, by Action Mechanism, 2019–2028 (USD Million)

9.4.7        UAE: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)

9.4.7.1      UAE: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)

9.4.7.2      UAE: Antibiotics Market, by Drug Class, 2019–2028 (USD Million)

9.4.7.3      UAE: Antibiotics Market, by Action Mechanism, 2019–2028 (USD Million)

9.4.8        South Africa: Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

9.4.8.1      South Africa: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)

9.4.8.2      South Africa: Antibiotics Market, by Drug Class, 2019–2028 (USD Million)

9.4.8.3      South Africa: Antibiotics Market, by Action Mechanism, 2019–2028 (USD Million)

9.5       South and Central America: Antibiotics Market

9.5.1        Overview

9.5.2        South and Central America: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)

9.5.3        South and Central America: Antibiotics Market, by Drug Class, 2019–2028 (USD Million)

9.5.4        South and Central America: Antibiotics Market, by Action Mechanism, 2019–2028 (USD Million)

9.5.5        South and Central America: Antibiotics Market, by Country, 2020 & 2028 (%)

9.5.6        Brazil: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)

9.5.6.1      Brazil: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)

9.5.6.2      Brazil: Antibiotics Market, by Drug Class, 2019–2028 (USD Million)

9.5.6.3      Brazil: Antibiotics Market, by Action Mechanism, 2019–2028 (USD Million)

9.5.7        Argentina: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)

9.5.7.1      Argentina: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)

9.5.7.2      Argentina: Antibiotics Market, by Drug Class, 2019–2028 (USD Million)

9.5.7.3      Argentina: Antibiotics Market, by Action Mechanism, 2019–2028 (USD Million)

10.         IMPACT OF COVID-19 PANDEMIC ON GLOBAL ANTIBIOTICS MARKET

10.1    North America: Impact assessment of COVID-19 Pandemic

10.2    Europe: Impact assessment of COVID-19 Pandemic

10.3    Asia-Pacific: Impact assessment of COVID-19 Pandemic

10.4    Rest of World: Impact assessment of COVID-19 Pandemic

11.         Antibiotics Market –Industry Landscape

11.1    Overview

11.2    Growth Strategies in The Antibiotics Market, 2016-2020

11.3    Inorganic Growth Strategies

11.3.1     Overview

11.4    Organic Growth Strategies

11.4.1     Overview

12.         COMPANY PROFILES

12.1    GlaxoSmithKline plc.

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2    Sanofi

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3    Novartis AG

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4    Pfizer Inc.

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5    Bayer AG

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6    Johnson & Johnson Services, Inc.

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7    Bristol-Myers Squibb Company

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8    Astellas Pharma Inc.

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

12.9    Abbott

12.9.1     Key Facts

12.9.2     Business Description

12.9.3     Products and Services

12.9.4     Financial Overview

12.9.5     SWOT Analysis

12.9.6     Key Developments

12.10 Eli Lilly and Company.

12.10.1   Key Facts

12.10.2   Business Description

12.10.3   Products and Services

12.10.4   Financial Overview

12.10.5   SWOT Analysis

12.10.6   Key Developments

13.         Appendix

13.1    About The Insight Partners

13.2    Glossary of Terms

LIST OF TABLES

Table 1.            North America Antibiotics Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)

Table 2.            North America Antibiotics Market, by Action Mechanism – Revenue and Forecast to 2028 (USD Million)

Table 3.            US Antibiotics Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)

Table 4.            US Antibiotics Market, by Action Mechanism – Revenue and Forecast to 2028 (USD Million)

Table 5.            Canada Antibiotics Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)

Table 6.            Canada Antibiotics Market, by Action Mechanism – Revenue and Forecast to 2028 (USD Million)

Table 7.            Mexico Antibiotics Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)

Table 8.            Mexico Antibiotics Market, by Action Mechanism – Revenue and Forecast to 2028 (USD Million)

Table 9.            Europe Antibiotics Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)

Table 10.          Europe Antibiotics Market, by Action Mechanism – Revenue and Forecast to 2028 (USD Million)

Table 11.          Germany Antibiotics Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)

Table 12.          Germany Antibiotics Market, by Action Mechanism – Revenue and Forecast to 2028 (USD Million)

Table 13.          UK Antibiotics Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)

Table 14.          UK Antibiotics Market, by Action Mechanism – Revenue and Forecast to 2028 (USD Million)

Table 15.          France Antibiotics Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)

Table 16.          France Antibiotics Market, by Action Mechanism – Revenue and Forecast to 2028 (USD Million)

Table 17.          Spain Antibiotics Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)

Table 18.          Spain Antibiotics Market, by Action Mechanism – Revenue and Forecast to 2028 (USD Million)

Table 19.          Italy Antibiotics Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)

Table 20.          Italy Antibiotics Market, by Action Mechanism – Revenue and Forecast to 2028 (USD Million)

Table 21.          Asia Pacific Antibiotics Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)

Table 22.          Asia Pacific Antibiotics Market, by Action Mechanism – Revenue and Forecast to 2028 (USD Million)

Table 23.          China Antibiotics Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)

Table 24.          China Antibiotics Market, by Action Mechanism – Revenue and Forecast to 2028 (USD Million)

Table 25.          Japan Antibiotics Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)

Table 26.          Japan Antibiotics Market, by Action Mechanism – Revenue and Forecast to 2028 (USD Million)

Table 27.          India Antibiotics Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)

Table 28.          India Antibiotics Market, by Action Mechanism – Revenue and Forecast to 2028 (USD Million)

Table 29.          South Korea Antibiotics Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)

Table 30.          South Korea Antibiotics Market, by Action Mechanism – Revenue and Forecast to 2028 (USD Million)

Table 31.          Australia Antibiotics Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)

Table 32.          Australia Antibiotics Market, by Action Mechanism – Revenue and Forecast to 2028 (USD Million)

Table 33.          Middle East & Africa Antibiotics Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)

Table 34.          Middle East & Africa Antibiotics Market, by Action Mechanism – Revenue and Forecast to 2028 (USD Million)

Table 35.          Saudi Arabia Antibiotics Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)

Table 36.          Saudi Arabia Antibiotics Market, by Action Mechanism – Revenue and Forecast to 2028 (USD Million)

Table 37.          UAE Antibiotics Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)

Table 38.          UAE Antibiotics Market, by Action Mechanism – Revenue and Forecast to 2028 (USD Million)

Table 39.          South Africa Antibiotics Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)

Table 40.          South Africa Antibiotics Market, by Action Mechanism – Revenue and Forecast to 2028 (USD Million)

Table 41.          South and Central America Antibiotics Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)

Table 42.          South and Central America Antibiotics Market, by Action Mechanism – Revenue and Forecast to 2027  (USD Million)

Table 43.          Brazil Antibiotics Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)

Table 44.          Brazil Antibiotics Market, by Action Mechanism – Revenue and Forecast to 2028 (USD Million)

Table 45.          Argentina Antibiotics Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)

Table 46.          Argentina Antibiotics Market, by Action Mechanism – Revenue and Forecast to 2028 (USD Million)

Table 47.          Recent Inorganic Growth Strategies in the antibiotics Market

Table 48.          Recent Organic Growth Strategies In The Antibiotics Market

Table 49.             Glossary of Terms, Antibiotics Market  


LIST OF FIGURES

Figure 1.           Antibiotics Market Segmentation

Figure 2.           Antibiotics Segmentation, By Region

Figure 3.           Global Antibiotics Market Overview

Figure 4.           The Cephalosporin Segment Held Largest Share Of Drug Class Segment In Antibiotics Market

Figure 5.           Asia-Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           Global Antibiotics Market, By Geography (US$ Million)

Figure 7.           Global Antibiotics Market- Leading Country Markets (US$ Million)

Figure 8.           Global Antibiotics Market, Industry Landscape

Figure 9.           North America PEST Analysis

Figure 10.        Europe PEST Analysis

Figure 11.        Asia Pacific PEST Analysis

Figure 12.        Middle East & Africa PEST Analysis

Figure 13.        South & Central America PEST Analysis

Figure 14.        Antibiotics market impact analysis of driver and restraints

Figure 15.        Global Antibiotics Market – Revenue Forecast And Analysis – 2019- 2027

Figure 16.        Global Antibiotics Market – By Geography Forecast And Analysis – 2019- 2027

Figure 17.        Market Positioning Of Key Players In Global Antibiotics Market

Figure 18.        Antibiotics Market Revenue Share, by Drug Class (2020 and 2028)

Figure 19.        Sulfonamides: Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.        Aminoglycosides: Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.        Carbapenem: Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.        Macrolides: Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23.        Fluoroquinolones: Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24.        Penicillin: Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.        Cephalosporin: Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.        Others: Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27.        Antibiotics Market, by Action Mechanism, 2020 and 2028 (%)

Figure 28.        Mycolic Acid Inhibitors: Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29.        RNA Synthesis Inhibitors: Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30.        DNA Synthesis Inhibitors: Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 31.        Protein Synthesis Inhibitors: Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 32.        Cell Wall Synthesis Inhibitors: Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 33.        Others: Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 34.        North America: Antibiotics Market, by Key Country – Revenue (2019) (USD Million)

Figure 35.        North America Antibiotics Market Revenue and Forecast to 2028 (USD Million)

Figure 36.        North America: Antibiotics Market, by Country, 2020 & 2028 (%)

Figure 37.        US: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)

Figure 38.        Canada: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)

Figure 39.        Mexico: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)

Figure 40.        Europe: Antibiotics Market, by Key Country – Revenue (2019) (USD Million)

Figure 41.        Europe Antibiotics Market Revenue and Forecast to 2028 (USD Million)

Figure 42.        Europe: Antibiotics Market, by Country, 2020 & 2028 (%)

Figure 43.        Germany: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)

Figure 44.        UK: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)

Figure 45.        France: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)

Figure 46.        Spain: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)

Figure 47.        Italy: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)

Figure 48.        Asia Pacific: Antibiotics Market, by Key Country – Revenue (2019) (USD Million)

Figure 49.        Asia Pacific Antibiotics Market Revenue and Forecast to 2028 (USD Million)

Figure 50.        China: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)

Figure 51.        Japan: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)

Figure 52.        India: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)

Figure 53.        South Korea: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)

Figure 54.        Australia: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)

Figure 55.        Middle East & Africa: Antibiotics Market, by Key Country – Revenue (2019) (USD Million)

Figure 56.        Middle East & Africa Antibiotics Market Revenue and Forecast to 2028 (USD Million)

Figure 57.        Middle East & Africa: Antibiotics Market Share by Country – 2019 & 2027, (%)

Figure 58.        Saudi Arabia: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)

Figure 59.        UAE: Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 60.        South Africa: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)

Figure 61.        South and Central America: Antibiotics Market, by Key Country – Revenue (2019) (USD Million)

Figure 62.        South and Central America Antibiotics Market Revenue and Forecast to 2028 (USD Million)

Figure 63.        South and Central America: Antibiotics Market, by Country, 2020 & 2028 (%)

Figure 64.        Brazil: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)

Figure 65.        Argentina: Antibiotics Market – Revenue and Forecast to 2028 (USD Million)

Figure 66.        Impact Of Covid-19 Pandemic In North American Country Markets

Figure 67.        Impact Of Covid-19 Pandemic In Europe Country Markets

Figure 68.        Impact Of Covid-19 Pandemic In Asia-Pacific Country Markets

Figure 69.        Impact Of Covid-19 Pandemic In Rest Of World Country Markets

Figure 70.            Growth Strategies in The Antibiotics Market, 2016-2020

The List of Companies - Antibiotics Market

  1. Pfizer, Inc
  2. Johnson & Johnson Services, Inc. (Janssen Pharmaceuticals),
  3. Abbott,
  4.  GlaxoSmithKline Plc,
  5. Sanofi,
  6.  Novartis AG,
  7.  Bayer AG,
  8. Bristol Myers Squibb Company,
  9. Eli Lilly and Company,
  10. Astellas Pharma
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the antibiotics  market.

 

  • Highlights key business priorities in order to assist companies to realign their business strategies.

 

  • The key findings and recommendations highlight crucial progressive industry trends in the global antibiotics  market, thereby allowing players across the value chain to develop effective long-term strategies.

 

  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

 

  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

 

  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

 

TIPRE00003406
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Frequently Asked Questions

The North American region holds the largest market for the breast cancer screening. The United States held the largest market for antibiotics market and is expected to grow due to factors such as increasing number of rising in prevalence of breast cancer , growing developments for screening and imaging process by the companies and others.

The growth of the market is attributed to some key driving factors such as rising prevalence of bacterial infections, growing geriatric population and increasing development of generic drugs. However, tedious and expensive process of antibiotic development is expected to restraint the growth of the market during the forecast years.

Antibiotics are powerful medicines that are used to fight against bacterial infections. Antibiotics are also known as antibacterials which include a range of powerful drugs and are used to treat diseases caused by bacteria. These are specifically used to treat infections caused by bacteria such as, Staph., Strep., or E. coli. and either kill the bacteria (bactericidal) or keep it from reproducing and growing (bacteriostatic). The antibiotics do not work against any viral infection. Some common infections treated with antibiotics are, conjunctivitis, skin or soft tissue infection, upper respiratory tract infection, bronchitis, streptococcal pharyngitis (strep throat) and among others.

Pricing
Contact Us : +1-646-491-9876 | +91-20-67271633 | Email : sales@theinsightpartners.com
© Copyright 2021 - The Insight Partners. All rights reserved